Education/Training
University of Wisconsin, Madison, WI B.S. 1972 Biochemistry
University of Utah, Salt Lake City, UT Ph.D. 1977 Microbiology
Wayne State University, Detroit, MI M.D. 1983 Medicine
Medical College of Wisconsin, Milwaukee, WI Resident 1987 Ophthalmology
Medical College of Wisconsin, Milwaukee, WI Fellowship 1988 Cornea/External Disease
Research and Professional Experience
1988 1991 Assistant Professor, Department of Ophthalmology, University of Arizona, Tucson, Arizona
1989 1991 Acting Head, Department of Ophthalmology, University of Arizona, Tucson, Arizona
1991-1997 Department Head and Associate Professor, Department of Ophthalmology, University of Arizona
1998-2004 Department Head and Professor, Department of Ophthalmology, University of Arizona,
2003-2004 President Ocular Microbiology and Immunology Group (OMIG)
2003-Present Professor with Tenure, Department of Biomedical Engineering, University of Arizona,
Selected Awards
1996 Humanitarian of the Year, State Lions of Arizona
1998- Present Selected by peers to "The Best Doctors in America"
1998-Present Selected by peers to “The Best Doctors in Tucson”
2000 Achievement Certificate, The Board of Trustees of the American Academy of Ophthalmology,
2000 Outstanding service and dedication to restoring vision to our patients, Lions Sight and Hearing
2000 Research to Prevent Blindness Unrestricted/Challenge Grant
2002 Best Paper Leiter Award – Ocular Microbiology and Immunology Group
Selected Publications
Thesis
Snyder, RW: Plasminogen activator from cultured baby hamster kidney cells. Ph.D. Thesis, University of Utah, 1977.
Advisors : Hill DW,Summers DF,Lombardi PS,O’Neil FJ,Capechi M *
Chapters
Hyndiuk RA, Snyder, RW: Bacterial Keratitis. In Smolin G and Thoft RA (eds.), The Cornea: Scientific Foundations and Clinical Practices. Boston and Toronto, Little Co., 1987.
Snyder, RW, Hyndiuk RA: Bacteria Mechanisms of Corneal Invasion. In: Duane JD, Jaeger EA (eds.). Biomedical Foundations of Ophthalmology, Vol 2, 1988.
Snyder, RW, Donnenfeld ED: Teaching Phaco to Residents and Physicians in Transition. In: International Ophthalmology Clinics, Volume 34, Number 2, Spring 1994. Little, Brown and Company. (O)
Snyder, RW, Jahnke J: Pathogenesis of Corneal Infections. In: Infections of the Eye, Second Edition. Little, Brown and Company, 1996.
Trookman N, Snyder, RW: Parinaud's Oculoglandular Syndrome. In: Diseases of the Eye and Skin. Raven Press, New York, NY, 1996.
Snyder, RW, Noecker RJ: Laser Cataract Surgery. In: Ophthalmology Clinics of North America, Berlin, M (ed), Volume 11, Number 2, June, 1998. W.B. Saunders Company, Philadelphia, PA.
Schwiegerling J, MacRae SM, Snyder RW: Aberrations and ablation pattern design. In: MacRae S, Krueger R, Applegate RA (Eds), Customized Corneal Ablation: The Quest for Super Vision. Slack, 2001.
Papers
1. Snyder RW, Stamer WD, Seftor REB: Corticosteroid treatment and trabecular meshwork proteases in cell and organ culture supernatants. Exp Eye Res. 1993; 57(4):461 468.
2. Donnenfeld ED, Schrier A, Perry HD, Aulicino T, Gombert ME, Snyder R: Penetration of topically applied ciprofloxacin, norfloxacin, and ofloxacin into the aqueous humor. Ophthalmology 1994: 101, 5: 902 905.
3. Stamer WD, Snyder RW, Smith BL, Agre P *, Regan JW: Localization of aquaporin CHIP in the human eye: Implications in the pathogenesis of glaucoma and other disorders of ocular fluid balance. Invest Ophthalmol Vis Sci. 1994; 35:3867 3872.
4. Seftor RE, Stamer WD, Seftor EA, Snyder RW: Dexamethasone decreases tissue plasminogen activator activity in trabecular meshwork organ and cell cultures. J of Glaucoma 1994; 3: 323 238.
5. Stamer WD, Seftor RE, Williams, Kramer TR, Snyder RW: Isolation and culture of human trabecular meshwork cells by extracellular matrix digestion. Curr Eye Res. 1995; 14: 611 617.
6. Stamer WD, Seftor RE, Snyder RW, Regan J: Cultured human trabecular meshwork cells express aquaporin 1 water channels. Curr Eye Res. 1995; 14: 1095 1100.
7. Schwiegerling J, Greivenkamp JE, Miller JM, Snyder RW, Palmer ML: Optical modeling of radial keratotomy incision patterns. Am J Ophthal. 1996; 122: 808 817.
8. Stamer WD, Snyder RW, Regan JW: Characterization of the transmembrane orientation of aquaporin 1 using antibodies to fusion proteins. Biochemistry 1996; 35: 16313 16318.
9. Stamer WD, Huang Y, Svennson SSP, Seftor REB, Snyder RW, Regan JW: Human trabecular meshwork cells express functional alpha 2A adrenergic receptors. Invest Ophthalmol Vis Sci. 1996; 37:2426 2433.
10. Donnenfeld ED, Perry HD, Snyder RW, Moadel K, Elsky M, Jones H: Intracorneal, aqueous humor and vitreous humor presentation of topical and oral ofloxacin. Arch Ophthalmol. 1997; 115: 173 176.
11. Schwiegerling J and Snyder RW: Custom photorefractive keratectomy ablations for the correction of spherical and cylindrical refractive error and higher order aberration. J. Optical Society of America, 1998; 15; 9: 2572 2579.
12. Schwiergerling J, Snyder RW: Visual performance modeling following RK, PRK, and LASIK demonstrates the need for improved treatment algorithms. Ophthalmic Practice, April 1999, Vol 17, No. 2, 66-70.
13. MacRae S, Schwiegerling J, Snyder RW; Customized and low spherical aberration corneal ablation design. J. of Refractive Surgery, Vol 15, MarchApril (suppl) 1999, S246-S248.
14. Boswell CA, Noecker RJ, Mac M, Snyder RW, Williams SK: Evaluation of an aqueous drainage glaucoma device constructed of ePTFE. J. Biomed Matter Res (Appl Biomater) 1999, 48:591-595.
15. Schwiegerling J, Snyder RW: Corneal ablation patterns to correct for spherical aberration in photorefractive keratectomy. J Cataract Refract Surg, Vol 26, February 2000, pp 214-221.
16. MacRae S, Schwiegerling J, Snyder R; Customized corneal ablation and super vision. J of Refractive Surgery, 2000, Vol 16, March/April (suppl). Munoz B, Sanchez R, West S, Broman A, Rodriguez J.
17. Quigley HA, West SK, Rodriguez J, Munoz B, Klein R, Snyder R: The prevalence of glaucoma in a population-based study of Hispanic subjects: Proyecto VER. Arch Ophthalmol. 2001;119:1819-1826.
18. Munoz B, Sanchez R, West S, Broman A, Rodriguez J, Snyder R, Klein R: Blindness, visual impairment and the problem of uncorrected refractive error in a Mexican-American population: Proyecto VER. Invest Ophthalmol Vis Sci. 2002; 43: 608-614.
19. Broman AT, West SK, Munoz B, Rodriguez J, Sanchez R, Klein R, Snyder R: The impact of visual impairment and eye disease on vision-related quality of life in a Mexican-American population: Proyecto VER. Invest Ophthalmol Vis Sci. 2002 Nov; 43(11):3393-3398.
20. Rodriguez J, Sanchez R, Munoz B, West SK, Broman A, Snyder R, Klein R, Quigley HA. Causes of blindness and visual impairment in a population-based sample of U.S. Hispanics. Ophthalmology. 2002; 109: 737-743.
21. Sidker S, Snyder RW. Femtosecond laser preparation of donor tissue from endothelial side. Cornea. 2006 May; 25 (4):416-22.
22. Oberg, TJ, Friday, JW, Ursea, R, Snyder RW. Is Tisseel A Viable Option In Posterior Lamellar Keratoplasty? Cornea. 2006 February.
Patents
Jani M, Yarborough JM, Marcellino G, Snyder RW, D’Amico DJ: Aspirating Handpieces for Laser Surgical Operations. Patent No. 6,120,498. Issued September 19, 2000.
Williams, S and Snyder RW: Glaucoma shunt and a method of making and surgically implanting the same. Patent No. 6,699,210 B2. Issued March 7, 2004.
Research Support
Federal/National
1987-1988 Principal Investigator: Fight-for-Sight Grant 87-026 – Intraocular Fibrinolysis using Human Tissue Plasminogen Activator, $6,400 (90% effort).
1991-1992 Principal Investigator: tPA Activity in Steroid Response Glaucoma, #1203EY099202-01 R03 grant – National Eye Institute of NIH - $23,045 (80% effort).
1996-1999 Co-Investigator: Blindness and Visual Impairment among Mexican Hispanics in Arizona. National Eye Institute of NIH - $3,631,378.
* Denotes Nobel Prize Winner
